Invention Grant
- Patent Title: Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
-
Application No.: US14188162Application Date: 2014-02-24
-
Publication No.: US09694089B2Publication Date: 2017-07-04
- Inventor: Milind Rajopadhye , Guojie Ho , Bohumil Bednar , Le T. Duong , Paul J. Coleman
- Applicant: Visen Medical, Inc. , Merck Sharp & Dohme Corp.
- Applicant Address: US MA Bedford US NJ Rahway
- Assignee: Visen Medical, Inc.,Merck Sharp & Dohme Corp.
- Current Assignee: Visen Medical, Inc.,Merck Sharp & Dohme Corp.
- Current Assignee Address: US MA Bedford US NJ Rahway
- Agency: Dinsmore & Shohl LLP
- Main IPC: A61K49/00
- IPC: A61K49/00 ; A61K49/04 ; A61K47/48 ; A61K49/08 ; A61K49/10 ; A61K49/18 ; A61K51/04 ; B82Y5/00 ; G01N33/574 ; C09B23/01 ; C09B23/08
Abstract:
The invention provides a family of agents that target integrins, which can be used as imaging agents and/or therapeutic agents. The agents can be used to image angiogenesis, inflammation or other physiological processes in a subject.
Public/Granted literature
- US20140170066A1 INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME Public/Granted day:2014-06-19
Information query
